<DOC>
	<DOCNO>NCT02537899</DOCNO>
	<brief_summary>SATURN investigate promising role NeuroAiD patient spinal cord injury provide important information feasibility conducting large control trial .</brief_summary>
	<brief_title>Spinal Cord Injury - Assessing Tolerability Use Combined Rehabilitation NeuroAiD</brief_title>
	<detailed_description>SATURN prospective cohort study patient moderately-severe severe spinal cord injury , define American Spinal Injury Association Impairment Scale A B , treat open-label NeuroAiD 6 month addition standard care follow 24 month . Anonymized data prospectively collected baseline month 1 , 3 , 6 , 12 , 18 , 24 use secure online system include information demographic , main diagnostics , neurological functional state , treatment compliance , concomitant therapy , side effect , .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Male female Age 18 65 year Diagnosed spinal cord injury 3 day 4 week American Spinal Injury Association Impairment Scale A B Informed consent inclusion database obtain Non survivable injury Multiple significant trauma ( i.e . significant intracranial extracranial injury include limb fracture ) would limit observation recovery spinal cord injury Other condition would limit clinical assessment outcome ( e.g . dementia , demyelinate disease , autoimmune disease , etc ) Refusal treatment contraindication NeuroAiD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>